Clinical Trials Directory

Trials / Terminated

TerminatedNCT00104624

Docetaxel in Treating Older Women With Metastatic Breast Cancer

Phase II Trial Assessing the Impact on Instrumental and Daily Living Autonomy of a Chemotherapy With Biweekly Docetaxel in the Treatment of Metastatic Breast Cancer in Patients Over 70

Status
Terminated
Phase
Phase 2
Study type
Interventional
Enrollment
53 (estimated)
Sponsor
UNICANCER · Academic / Other
Sex
Female
Age
70 Years
Healthy volunteers
Not accepted

Summary

RATIONALE: Drugs used in chemotherapy, such as docetaxel, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. PURPOSE: This phase II trial is studying how well docetaxel works in treating older women with metastatic breast cancer and whether it helps improve the ability to perform daily activities.

Detailed description

OBJECTIVES: Primary * Determine degree of autonomy in instrumental activities of daily living on-therapy and at 6 and 12 months, as measured by Lawton's Instrumental Activities of Daily Living Scale, in older women with metastatic adenocarcinoma of the breast treated with docetaxel. Secondary * Determine the response rate in patients treated with this drug. * Determine overall and progression-free survival of patients treated with this drug. * Determine the degree of autonomy in daily activities as measured by Katz's Activities of Daily Living Scale, in patients treated with this drug. * Determine mood status, as measured by the Geriatric Depression Scale, of patients treated with this drug. * Determine toxicity of this drug in these patients. OUTLINE: This is a multicenter study. Patients receive docetaxel IV on days 1 and 15. Treatment repeats every 28 days for 6 courses. Ability to perform daily activities is assessed periodically. PROJECTED ACCRUAL: A total of 53 patients will be accrued for this study.

Conditions

Interventions

TypeNameDescription
DRUGdocetaxel
PROCEDUREquality-of-life assessment

Timeline

Start date
2005-05-01
Primary completion
2007-07-01
Completion
2008-07-01
First posted
2005-03-04
Last updated
2013-09-04

Locations

7 sites across 3 countries: France, Italy, Switzerland

Source: ClinicalTrials.gov record NCT00104624. Inclusion in this directory is not an endorsement.